QML - First Southern Hemisphere install of the i6000

Abbott Diagnostics is excited about the first ever i6000 installation in the Southern Hemisphere! 

The installation of the i6000 at the QML site in Queensland was borne out of a need to increase test throughput on the laboratory’s existing ARCHITECT i4000.

“When Abbott expanded its ARCHITECT Assay Menu recently to include Rubella G and M and Rubella CMV G and M  to their ARCHITECT Assay Menu,  coupled with a growth in our test numbers and restricted space, the option of an i6000 was the best solution for us,” says Peter O’Loughlin, QML Laboratory Supervisor.

All high volume assays (HBsAg, Anti-HBs, Anti-HCV and HIV COMBO ) are loaded on each of the three ARCHITECT modules, with lower volume assays being evenly distributed across the modules.  The i6000 provides 75 reagent positions on one analyser, permitting up to 37,500 tests to be loaded onto the i6000 at one time, increasing test throughput to close to 600 tests per hour.  These tests are in addition to other routine ARCHITECT assays including  HIV COMBO;  HbsAg; - Anti-HBc;  Anti-HBs;  Anti-HBc IgM;  Anti-Hbe;  Hbe;  HAVAB-G;  HAVAB-M;  Anti-HCV and   Syphilis.

The engineering team at Abbott were responsible for building the new integrated instrument. “We inserted an ARCHITECT i2000 between the original i4000 modules,” said State Sales Manager, Marc Stevens. “

“The throughput is impressive and we are pleased with what the ARCHITECT i6000 can deliver,” said Peter O’Loughlin. “The benefit of the upgrade is increased throughput and increased redundancy of analysis modules all in a compact footprint,” added Peter O’Loughlin.

George Maleeevsky, Mary-Ellen Costello and Renee Shepherd all operators of the i6000 in the QML Immulogy Department at their main laboratory in Murarrie in Brisbane